Clinical Trials

The following clinical trials are currently recruiting participants. If you would like more information about the trial or how to participate, please contact the study coordinator.

Trial Name	Title	Sponsor	Condition	Status	Study Coordinator
Vit D	Impact of vitamin D therapies on monocyte function in chronic kidney disease	Internal Medicine-K12	CKD stage 3/4	Recruiting	Cathy Creed
NOCTURNE 290	Double-blinded trial to compare the efficacy, tolerability, and safety of Tolvaptan. Modified and Immediate release formulations in subjects with ADPKD	Otsuka	ADPKD	Recruiting	Sheri Copeland
OVERTURE 291	A multi-center, longitudinal, observational study of subjects with ADPKD	Otsuka	ADPKD	Recruiting	Cathy Creed
MODIFIER ADPKD study	Identifying genetic modifiers in ADPKD	NIH	ADPKD	Recruiting	Cathy Creed
FONT II	Novel therapies for resistant focal segmental glomerulosclerosis (FSGS): A phase 2 clinical trial	NIH	FSGS	Recruiting	Beth Courtney
MENTOR	Membranous nephropathy trial of Rituximab multi-center randomized controlled trial of Rituximad Vs Cycolsporine in the TX of idiopathis membranous nephropathy (IMN)	NIH	ADKPKD	Recruiting	Cathy Creed

Abbreviations: CKD, chronic kidney disease; ESRD, end-stage renal disease; ADPKD, autosomal dominant polycystic kidney disease; FSGS, focal segmental glomerulosclerosis

The following clinical trials are active and NOT currently recruiting participants. If you would like more information about the trial, please contact the study coordinator.

Trial Name	Title	Sponsor	Condition	Status	Study Coordinator
TEMPO 3(271)	Multi-center, open-label, extension study to evaluate the long-term efficacy and safety of oral tolvaptan tablet regimens in subjects with autosomal dominant polycystic kidney disease	Otsuka	ADPKD	Active/Not Recruiting	Sheri Copeland
CRISP 3	Consortium for radiologic imaging studies of polycystic kidney disease	NIH	ADPKD	Active/Not Recruiting	Marilyn Logan Beth Courtney
HALT-PKD	Halt progression of polycystic kidney disease: efficacy of renin-angiotensin-aldosterone axis blockade in preventing/slowing renal function decline in ADPKD	NIH	ADPKD	Active/Not Recruiting	Pam Lanza Beth Courtney

Contact information

Sheri Copeland RN, Lead Study Coordinator (913) 588-7691 scopeland2@kumc.edu

Cathy Creed RN, Study Coordinator (913) 588-0053 ccreed@kumc.edu

Elizabeth Courtney RN, Study Coordinator (913) 588-7609 bcourtney@kumc.edu

Pam Lanza RN, Study Coordinator (913) 588-8983 planza@kumc.edu

Marilyn Logan,RN Study Coordinator (913) 588-3985 mlogan@kumc.edu

Last modified: Apr 02, 2013

Events

Information for:

Academics

Nephrology and Hypertension

Clinical Trials